U.S. may expand Nvidia and AMD’s 15% China chips deal to other companies
CHICAGO - Vodori, a provider of cloud-based software for content review and approval in the life sciences industry, launched its new application on the Salesforce (NYSE:CRM) AppExchange on Tuesday.
The application enables life sciences organizations to distribute approved promotional and medical content within Salesforce Life Sciences Cloud, which is built on Sales and Service Clouds platforms.
According to the company’s press release statement, the app automatically distributes MLR-approved materials to Salesforce while withdrawing outdated or expired content, aiming to streamline workflows between content approval and distribution processes.
"This launch indicates something powerful: life sciences companies now have a choice on how they want to manage regulated content," said Scott Rovegno, CEO of Vodori.
Tara Helm, Vice President of Life Sciences Cloud Strategy at Salesforce, stated, "Vodori’s integration with Life Sciences Cloud is a great example of how AppExchange partners can extend the power of our purpose-built, unified platform to meet highly specific industry needs."
The application features automated content synchronization, automatic withdrawals of expired materials, permission-based access, usage reporting, CRM integration, and multi-cloud compatibility.
Vodori’s platform serves pharmaceutical, medical device, and biotech companies seeking to streamline Medical (TASE:BLWV), Legal, and Regulatory (MLR) review processes and maintain promotional compliance. The new Salesforce integration extends this functionality to field representatives, service teams, and Medical Science Liaisons.
The application is now available on the Salesforce AppExchange.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.